Results 241 to 250 of about 29,857,715 (400)
A new assessment tool for neuropsychopharmacological research: The Computerized Neuropsychological Test Battery (CNTB) [PDF]
, 1990 Amy E. Veroff +3 more
openalex +1 more source
Assessing researchers with a focus on research integrity [PDF]
The Lancet, 2019 openaire +2 more sources
Common Data Set, 2008-2009 [PDF]
, 2008 Office of Institutional Research and Assessment, Bridgewater State College
core +1 more source
Molecular Oncology, EarlyView.This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci +6 more
wiley +1 more source
Assessment of Long-Term Research Needs for Coal-Liquefaction Technologies
, 1980 S.S. Penner
openalex +2 more sources
Common Data Set, 2004-2005 [PDF]
, 2004 Office of Institutional Research and Assessment, Bridgewater State College
core +1 more source
Landscape of BRAF transcript variants in human cancer
Molecular Oncology, EarlyView.We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda +5 more
wiley +1 more source
Assessment of research and development (R and D) needs in ammonia safety and environmental control
, 1981 David L. Brenchley +2 more
openalex +2 more sources
Common Data Set, 2009-2010 [PDF]
, 2009 Office of Institutional Research and Assessment, Bridgewater State College
core +1 more source
Loss of proton‐sensing GPR4 reduces tumor progression in mouse models of colon cancer
Molecular Oncology, EarlyView.G protein‐coupled receptor 4 (GPR4) is a pH‐sensing receptor activated by acidic pH. GPR4 expression is increased in patients with inflammatory bowel disease who are at high risk of developing colorectal cancer. In mouse models, loss of GPR4 attenuated tumor progression. This correlated with increased IL2 and natural killer cell activity.
Leonie Perren +16 more
wiley +1 more source